Pracgen has established a multi-level preparation platforms to provide customers with plasmid products and preparation services at different levels, including research level, high quality level and GMP level, which can be widely applied in gene therapy, cell therapy, mRNA preparation process.
Pracgen owns several plasmid vectors with independent intellectual property rights to meet the application needs of gene and cell therapy.
Pracgen has established a quality management system that meets GMP requirements to provide plasmid process development services in line with the requirements of IND application.
High efficiency: the expression up to 200-300mg/L; ready-to-use plasmid available.
Stable plasmid source ensures their consistency
High-sensitivity detection methods and strict release standards
No animal origins or antibiotics used
Purity is high; Low impurities
Plasmids available for sale
Name | Concentration | volume | application field | Price |
pMD2.G-YH | 1mg/ml | 1ml | Lentivirus packaging | Quote |
pRSV/RRE-YH | 1mg/ml | 1ml | Lentivirus packaging | |
pMDL.g-YH | 1mg/ml | 1ml | Lentivirus packaging | |
pCMV-RD114 | 1mg/ml | 1ml | Retrovirus packaging | |
pBHK21-gp | 1mg/ml | 1ml | Retrovirus packaging |
Process development service content and price
Name | Period | Delivery standard | Price |
Strain screening | 2-3 weeks | Meet ChP requirements | Quote |
Three-level strains bank establishment | 3-4 weeks | Meet ChP requirements | |
Fermentation process development and validation | 1.5-3 months | Subject to contract | |
Purification process development and validation | 1.5-3 months | Subject to contract | |
Formulation development | 1.5-2 months | Subject to contract | |
Study on stability of preparation | 6 months – 2 years | Subject to contract | |
Test methodology development | Depending on method | Meet ChP requirements | |
Depending on method | Meet ChP requirements |